Development of an Affordable ELISA Targeting the SARS-CoV-2 Nucleocapsid and Its Application to Samples from the Ongoing COVID-19 Epidemic in Ghana

[1]  E. Delaporte,et al.  Population-based sero-epidemiological investigation of the dynamics of SARS-CoV-2 infections in the Greater Accra Region of Ghana , 2022, Scientific reports.

[2]  J. Rayner,et al.  Probing SARS-CoV-2-positive plasma to identify potential factors correlating with mild COVID-19 in Ghana, West Africa , 2022, BMC Medicine.

[3]  J. Arapović,et al.  SARS-CoV-2 Spike and Nucleocapsid Antibody Response in Vaccinated Croatian Healthcare Workers and Infected Hospitalized Patients: A Single Center Cohort Study , 2022, Viruses.

[4]  D. Volke,et al.  Sensitive and specific serological ELISA for the detection of SARS-CoV-2 infections , 2022, Virology Journal.

[5]  Minli You,et al.  Emerging ELISA Derived Technologies for in vitro Diagnostics , 2022, TrAC Trends in Analytical Chemistry.

[6]  N. Xia,et al.  The Protection of Naturally Acquired Antibodies Against Subsequent SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis , 2022, Emerging microbes & infections.

[7]  G. Ghartey-Kwansah,et al.  Low incidence of COVID-19 case severity and mortality in Africa; Could malaria co-infection provide the missing link? , 2022, BMC Infectious Diseases.

[8]  C. Bahloul,et al.  Development of an in-house quantitative ELISA for the evaluation of different Covid-19 vaccines in humans , 2022, Scientific Reports.

[9]  R. Eason,et al.  A SARS-CoV-2 nucleocapsid ELISA represents a low-cost alternative to lateral flow testing for community screening in LMI countries , 2021, Journal of Infection.

[10]  I. Mazo,et al.  IgG Antibodies Develop to Spike but Not to the Nucleocapsid Viral Protein in Many Asymptomatic and Light COVID-19 Cases , 2021, Viruses.

[11]  J. Marschall,et al.  Serological testing for SARS‐CoV‐2 antibodies in clinical practice: A comparative diagnostic accuracy study , 2021, Allergy.

[12]  O. Quaye,et al.  Trends of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody prevalence in selected regions across Ghana , 2021, Wellcome Open Research.

[13]  Shupeng Jiang,et al.  Development of a Nucleocapsid Protein-Based ELISA for Detection of Human IgM and IgG Antibodies to SARS-CoV-2 , 2021, ACS omega.

[14]  R. Müller,et al.  Evaluation of a New Spike (S)-Protein-Based Commercial Immunoassay for the Detection of Anti-SARS-CoV-2 IgG , 2021, medRxiv.

[15]  H. Achdout,et al.  Spike vs nucleocapsid SARS-CoV-2 antigen detection: application in nasopharyngeal swab specimens , 2021, Analytical and Bioanalytical Chemistry.

[16]  B. Lu,et al.  Development and application of sensitive, specific, and rapid CRISPR‐Cas13‐based diagnosis , 2021, Journal of medical virology.

[17]  H. Gendelman,et al.  Diagnostics for SARS-CoV-2 infections , 2021, Nature Materials.

[18]  M. Fay,et al.  Standardization of ELISA protocols for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood sampling , 2021, Nature communications.

[19]  M. Barry,et al.  Understanding the Challenges and Uncertainties of Seroprevalence Studies for SARS-CoV-2 , 2020, International journal of environmental research and public health.

[20]  Y. Yazdanpanah,et al.  A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations , 2020, Science Translational Medicine.

[21]  M. Peeters,et al.  Multiplex detection and dynamics of IgG antibodies to SARS-CoV2 and the highly pathogenic human coronaviruses SARS-CoV and MERS-CoV , 2020, Journal of Clinical Virology.

[22]  K. Raahemifar,et al.  Use of microwave ablation for thermal treatment of solid tumors with different shapes and sizes—A computational approach , 2020, PloS one.

[23]  S. Ciesek,et al.  Clinical performance of different SARS‐CoV‐2 IgG antibody tests , 2020, Journal of medical virology.

[24]  Sairaj Satarker,et al.  Structural Proteins in Severe Acute Respiratory Syndrome Coronavirus-2 , 2020, Archives of Medical Research.

[25]  Mario Plebani,et al.  Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19) , 2020, Clinical chemistry and laboratory medicine.

[26]  Andrea Benedetti,et al.  Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis , 2020, BMJ.

[27]  Fernando Guerrero,et al.  Tandem SUMO fusion vectors for improving soluble protein expression and purification. , 2015, Protein expression and purification.

[28]  P. Lim,et al.  Antibody Response of Patients with Severe Acute Respiratory Syndrome (SARS) Targets the Viral Nucleocapsid , 2004, The Journal of infectious diseases.